Amends TCA Title 39; Title 53; Title 63 and Title 68.
Tennessee HB2136 mandates the Department of Health to compile and submit a report detailing each medication approved by the FDA for women's health, including a synopsis of each medication, to the Speaker of the Senate and the Speaker of the House of Representatives by January 1, 2027. This bill affects state health reporting practices and aims to enhance legislative awareness of women's health medications. Key provisions include the requirement for a comprehensive report and the specified deadline for submission.
Tennessee HB2136 mandates the Department of Health to compile and submit a report detailing each medication approved by the FDA for women's health, including a synopsis of each medication, to the Speaker of the Senate and the Speaker of the House of Representatives by January 1, 2027. This bill affects state health reporting practices and aims to enhance legislative awareness of women's health medications. Key provisions include the requirement for a comprehensive report and the specified deadline for submission.
Track Tennessee Legislation Like a Pro
Join hundreds of professionals using LegisGo to stay ahead of legislative changes.
Instant Alerts
Get notified when bills you track move through the legislature
AI Summaries
Understand complex legislation in seconds with AI-powered analysis
Full Access
All 132 legislators, committee schedules, and voting records